Rolofylline

From Ganfyd

Jump to: navigation, search

An adenosine A(1) receptor antagonist whose development was discontinued in June 2009 after poor results in heart failure trials as of 2010 unpublished. It facilitates immediate diuresis and preserves renal function in acute decompensated heart failure[1] at the risk of seizures[2].

References

Personal tools